Ruth Savage

1.7k total citations · 1 hit paper
33 papers, 1.2k citations indexed

About

Ruth Savage is a scholar working on Pharmacology, Surgery and Oncology. According to data from OpenAlex, Ruth Savage has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Ruth Savage's work include Drug-Induced Adverse Reactions (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Ruth Savage is often cited by papers focused on Drug-Induced Adverse Reactions (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Ruth Savage collaborates with scholars based in New Zealand, Sweden and United Kingdom. Ruth Savage's co-authors include L.A. García Rodríguez, Yola Moride, Susana Perez‐Gutthann, David Henry, L. Lim, Robert A. Logan, Marie R. Griffin, S. Hill, Christopher J. Hawkey and Jeffrey L. Carson and has published in prestigious journals such as BMJ, SLEEP and Clinical Pharmacokinetics.

In The Last Decade

Ruth Savage

31 papers receiving 1.1k citations

Hit Papers

Variability in risk of gastrointestinal complications wit... 1996 2026 2006 2016 1996 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Savage New Zealand 15 577 294 155 151 141 33 1.2k
Nuria Riera‐Guàrdia United States 12 522 0.9× 285 1.0× 163 1.1× 233 1.5× 107 0.8× 14 1.4k
Consuelo Huerta Spain 22 423 0.7× 553 1.9× 139 0.9× 361 2.4× 126 0.9× 66 2.3k
Federica Nicotra Italy 16 463 0.8× 331 1.1× 134 0.9× 487 3.2× 97 0.7× 21 1.5k
Arja Helin‐Salmivaara Finland 19 368 0.6× 382 1.3× 80 0.5× 285 1.9× 121 0.9× 37 1.4k
Heather Halls Australia 8 700 1.2× 428 1.5× 127 0.8× 460 3.0× 126 0.9× 13 1.6k
L.A. García Rodríguez Spain 10 760 1.3× 480 1.6× 160 1.0× 340 2.3× 112 0.8× 16 1.8k
David Campen United States 9 496 0.9× 202 0.7× 67 0.4× 259 1.7× 107 0.8× 11 1.1k
Bengt‐Erik Wiholm Sweden 14 309 0.5× 211 0.7× 84 0.5× 101 0.7× 103 0.7× 27 986
Michele M. Spence United States 13 472 0.8× 160 0.5× 86 0.6× 265 1.8× 149 1.1× 24 1.2k
Luisa Ibáñez Spain 21 248 0.4× 152 0.5× 88 0.6× 171 1.1× 264 1.9× 52 1.4k

Countries citing papers authored by Ruth Savage

Since Specialization
Citations

This map shows the geographic impact of Ruth Savage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Savage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Savage more than expected).

Fields of papers citing papers by Ruth Savage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Savage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Savage. The network helps show where Ruth Savage may publish in the future.

Co-authorship network of co-authors of Ruth Savage

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Savage. A scholar is included among the top collaborators of Ruth Savage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Savage. Ruth Savage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Savage, Ruth, et al.. (2023). Vulval Aphthous Ulcers in Adolescents Following COVID-19 Vaccination—Analysis of an International Case Series. Journal of Pediatric and Adolescent Gynecology. 36(4). 383–392. 5 indexed citations
3.
Russom, Mulugeta, et al.. (2021). Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database. Drugs - Real World Outcomes. 8(3). 263–275. 2 indexed citations
4.
Rocca, Elena, et al.. (2021). Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020. Drug Safety. 44(9). 987–998. 10 indexed citations
5.
Bennett, Miriam, Catherina L. Chang, Michael Tatley, Ruth Savage, & Robert J. Hancox. (2021). The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports. ERJ Open Research. 7(1). 801–2020. 20 indexed citations
6.
Savage, Ruth, et al.. (2020). E-Learning in Pharmacovigilance: An Evaluation of Microlearning-Based Modules Developed by Uppsala Monitoring Centre. Drug Safety. 43(11). 1171–1180. 19 indexed citations
7.
Savage, Ruth, et al.. (2019). Suspected Hepatotoxicity With a Supercritical Carbon Dioxide Extract of Artemisia annua in Grapeseed Oil Used in New Zealand. Frontiers in Pharmacology. 10. 1448–1448. 13 indexed citations
8.
Savage, Ruth, et al.. (2019). The Association between Metformin Therapy and Lactic Acidosis. Drug Safety. 42(12). 1449–1469. 22 indexed citations
9.
Savage, Ruth & Michael Tatley. (2018). Case Series Analysis of New Zealand Reports of Rapid Intense Potentiation of Warfarin by Roxithromycin. Drug Safety. 41(5). 515–521. 2 indexed citations
10.
Tatley, Michael, et al.. (2017). International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add Value. Seminars in Thrombosis and Hemostasis. 43(6). 635–638. 2 indexed citations
11.
Maggo, Simran, Ruth Savage, & Martin A. Kennedy. (2015). Impact of New Genomic Technologies on Understanding Adverse Drug Reactions. Clinical Pharmacokinetics. 55(4). 419–436. 15 indexed citations
12.
Savage, Ruth. (2013). Viewpoint: The New Zealand Centre for Adverse Reactions Monitoring: a source of practice-based evidence. Journal of Primary Health Care. 5(2). 170–173. 2 indexed citations
13.
Harrison‐Woolrych, Mira, Simran Maggo, Ming Tan, Ruth Savage, & Janelle Ashton. (2011). Cardiovascular Events in Patients taking Varenicline. Drug Safety. 35(1). 33–43. 24 indexed citations
15.
Tatley, Michael & Ruth Savage. (2007). Psychiatric Adverse Reactions with Statins, Fibrates and Ezetimibe. Drug Safety. 30(3). 195–201. 64 indexed citations
16.
Savage, Ruth, et al.. (2006). Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports. Internal Medicine Journal. 36(3). 162–169. 40 indexed citations
17.
Gwynne‐Jones, David, Ruth Savage, & John Highton. (2005). Synovitis induced by alendronic acid can present as acute carpal tunnel syndrome. BMJ. 330(7482). 74–74. 9 indexed citations
18.
Savage, Ruth. (2005). Cyclo-Oxygenase-2 Inhibitors. Drugs & Aging. 22(3). 185–200. 31 indexed citations
19.
Lindquist, Marie, Monica Pettersson, I. Ralph Edwards, et al.. (1997). How Does Cystitis Affect a Comparative Risk Profile of Tiaprofenic Acid with Other Non‐Steroidal Antiinflammatory Drugs? An International Study Based on Spontaneous Reports and Drug Usage Data. Pharmacology & Toxicology. 80(5). 211–217. 13 indexed citations
20.
Henry, David, L. Lim, L.A. García Rodríguez, et al.. (1996). Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ. 312(7046). 1563–1566. 614 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026